ATE136544T1 - Thiazolidinderivate mit antidiabetischer wirkung, ihre herstellung und anwendung - Google Patents

Thiazolidinderivate mit antidiabetischer wirkung, ihre herstellung und anwendung

Info

Publication number
ATE136544T1
ATE136544T1 AT91300959T AT91300959T ATE136544T1 AT E136544 T1 ATE136544 T1 AT E136544T1 AT 91300959 T AT91300959 T AT 91300959T AT 91300959 T AT91300959 T AT 91300959T AT E136544 T1 ATE136544 T1 AT E136544T1
Authority
AT
Austria
Prior art keywords
production
thiazolidine derivatives
hydrogen
antidiabetic effect
chem
Prior art date
Application number
AT91300959T
Other languages
English (en)
Inventor
Takao Yoshioka
Takashi Fujita
Tsutomu Kanai
Kanichi Nakamura
Hiroyoshi Hirikoshi
Kunihiro Sasahara
Takeshi Kinoshita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE136544T1 publication Critical patent/ATE136544T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT91300959T 1990-02-07 1991-02-06 Thiazolidinderivate mit antidiabetischer wirkung, ihre herstellung und anwendung ATE136544T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2802390 1990-02-07

Publications (1)

Publication Number Publication Date
ATE136544T1 true ATE136544T1 (de) 1996-04-15

Family

ID=12237153

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91300959T ATE136544T1 (de) 1990-02-07 1991-02-06 Thiazolidinderivate mit antidiabetischer wirkung, ihre herstellung und anwendung

Country Status (11)

Country Link
US (1) US5143930A (de)
EP (1) EP0441605B1 (de)
KR (1) KR0184601B1 (de)
AT (1) ATE136544T1 (de)
AU (1) AU637456B2 (de)
CA (1) CA2035832C (de)
DE (1) DE69118565T2 (de)
DK (1) DK0441605T3 (de)
ES (1) ES2088459T3 (de)
FI (1) FI910583A7 (de)
GR (1) GR3020196T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012003A1 (en) * 1990-02-09 1991-08-22 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
NO302471B1 (no) * 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
ES2139633T3 (es) * 1992-08-31 2000-02-16 Sankyo Co Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica.
FR2696743B1 (fr) * 1992-10-12 1994-12-23 Adir Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.
TW245716B (de) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
JP3195455B2 (ja) * 1993-01-06 2001-08-06 ウェルファイド株式会社 キノリン−３−酢酸誘導体、その製造法と用途
TW268952B (de) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
CZ289317B6 (cs) * 1994-04-11 2002-01-16 Sankyo Company Limited Heterocyklická sloučenina, farmaceutický prostředek ji obsahující a její pouľití
CZ261095A3 (en) * 1994-10-07 1996-04-17 Sankyo Co Oxime derivatives, process of their preparation, pharmaceutical composition containing thereof and their use
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
CA2258949C (en) 1996-07-01 2008-05-06 Reddy-Cheminor, Inc. Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
TW475931B (en) 1997-10-08 2002-02-11 Sankyo Co A substituted condensed heterocyclic compound
US6946295B2 (en) * 1998-06-12 2005-09-20 Cellfor, Inc. Process for ex vitro sowing and germination of plant somatic embryos
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
WO2002050024A2 (en) * 2000-12-18 2002-06-27 Smithkline Beecham Corporation Thiazolidinediones
KR20120107493A (ko) 2009-12-15 2012-10-02 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온염
MX2012012092A (es) 2010-04-19 2012-12-17 Metabolic Solutions Dev Co Llc Sintesis novedosa para compuestos de tiazolidinadiona.
PL2603498T3 (pl) 2010-08-10 2017-06-30 Octeta Therapeutics, Llc Nowa synteza związków tiazolidynodionu
US8895748B2 (en) 2010-08-10 2014-11-25 Metabolic Solutions Development Company, Llc Synthesis for thiazolidinedione compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US4933355A (en) * 1988-04-14 1990-06-12 Sankyo Company Limited Thiazole derivatives, their preparation and their use in the treatment of diabetes complications
GB8919434D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
CA2035832A1 (en) 1991-08-08
DE69118565D1 (de) 1996-05-15
DE69118565T2 (de) 1997-01-09
EP0441605A2 (de) 1991-08-14
CA2035832C (en) 2000-08-29
AU637456B2 (en) 1993-05-27
EP0441605A3 (en) 1992-01-22
DK0441605T3 (da) 1996-07-29
ES2088459T3 (es) 1996-08-16
AU7090691A (en) 1991-08-08
GR3020196T3 (en) 1996-09-30
US5143930A (en) 1992-09-01
FI910583A7 (fi) 1991-08-08
HK1005451A1 (en) 1999-01-08
KR910015552A (ko) 1991-09-30
EP0441605B1 (de) 1996-04-10
KR0184601B1 (ko) 1999-05-01
FI910583A0 (fi) 1991-02-07

Similar Documents

Publication Publication Date Title
ATE136544T1 (de) Thiazolidinderivate mit antidiabetischer wirkung, ihre herstellung und anwendung
ATE26120T1 (de) Substituierte acyl-derivate von 1,2,3,4tetrahydro-6,7-dimethoxy-3-isoquinolincarbons|ure.
DK543787D0 (da) Antibakterielle midler
DK0423714T3 (da) Hårrevitaliseringsmiddel
WO1998035951A3 (en) New aminopiperazine derivatives
DK0565721T3 (da) 1,4-Benzothiazepinderivat
ES2074594T3 (es) Derivados de 4-(4-alcoxifenil)-2-butilamina y su procedimiento de preparacion.
ATE158795T1 (de) Thiazolidindionderivate, ihre herstellung und anwendung
SE8406141D0 (sv) N-acylaminosyradiamidderivat, salter derav, forfarande for deras framstellning och antiulcermedel innehallande dessa
FI881104A0 (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
FI931346A0 (fi) Butadienderivat och foerfarande foer deras framstaellning
ES2028444T3 (es) Procedimiento para la preparacion de hidroxialquil-1 nitro-5 imidazoles.
ATE236162T1 (de) Pyrroloazepinderivate
HUT50788A (en) Process for producing phenoxyacetic acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ATE128131T1 (de) Substituierte pyridinsulfonamide oder deren salze, verfahren zur herstellung und diese enthaltende herbizide.
DE3873170D1 (de) Verwendung von -7-thiaprostaglandin e1 oder seinen derivaten zur herstellung eines antidiabetikums.
CA2092919A1 (en) Epoxysuccinamic acid derivatives
ATE126510T1 (de) Herstellung von isochinolinderivaten.
EP0432841A3 (en) Spiro-indoline-oxazine compounds with photochromatic and photosensitizing characteristics and the process for their preparation
DE3163803D1 (en) 2-methyl-5-thiazole-methylamine and carboxamide derivatives
ATE112682T1 (de) Isocarbacyclinderivate enthaltende antidiabetika.
ATE129246T1 (de) Pyrazolo(1,5-a)pyridine, deren herstellung und verwendung.
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.
DE3578168D1 (de) Aminoalkylnaphthalen-derivate mit pharmakologischer wirkung.
ATE63544T1 (de) 4-cyanopiperidine-derivate, herstellung und anwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee